
Techno Venture Management
Description
Techno Venture Management, widely recognized as TVM Capital, is a prominent venture capital and private equity firm with a dedicated focus on the healthcare industry. While the firm operates globally, its presence in Boston, United States, aligns with its significant activities in North American life sciences. Established in 1984, TVM Capital has built a long-standing reputation for identifying and nurturing innovative companies across the biotech, pharmaceutical, medical device, and digital health sectors.
The firm's investment strategy centers on early to mid-stage companies that possess disruptive technologies or therapies with the potential to address significant unmet medical needs. TVM Capital typically seeks out opportunities where its deep industry expertise and extensive network can add substantial value beyond just capital. They often engage in a hands-on approach, collaborating closely with management teams to navigate complex development pathways, regulatory hurdles, and market entry strategies.
TVM Capital has demonstrated substantial scale and impact within the healthcare investment landscape. Across its various funds, TVM Capital Life Science alone has successfully raised over $1.8 billion in capital since its inception. This capital has been strategically deployed to support the growth of a diverse portfolio, with the firm having invested in over 140 companies across North America and Europe. Their commitment to fostering innovation and driving advancements in healthcare solidifies their position as a key player in the venture capital ecosystem.
Investor Profile
Techno Venture Management has backed more than 98 startups, with 0 new investments in the last 12 months alone. The firm has led 20 rounds, about 20% of its total and boasts 37 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series B, Series A rounds (top funding stages).
- Majority of deals are located in United States, Germany, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
- Typical check size: $3M – $15M.
Stage Focus
- Series Unknown (38%)
- Series B (21%)
- Series A (15%)
- Series C (10%)
- Seed (4%)
- Series D (3%)
- Series E (2%)
- Post Ipo Equity (2%)
- Undisclosed (1%)
- Private Equity (1%)
Country Focus
- United States (55%)
- Germany (27%)
- United Kingdom (7%)
- Switzerland (4%)
- Austria (2%)
- The Netherlands (2%)
- France (1%)
- Israel (1%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Medical
- Software
- Information Technology
- Therapeutics
- Health Diagnostics
- Manufacturing
- Network Hardware
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.